M3 Wake Research Chattanooga

Clinical research site in Chattanooga, Tennessee

Part of M3 Wake Research

As of July 2026, 2 paid clinical trials are recruiting at M3 Wake Research Chattanooga in Chattanooga, Tennessee. Active studies at this site cover conditions such as Diabetic Peripheral Neuropathic Pain, Diabetes Mellitus and Overweight. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at M3 Wake Research Chattanooga (2)

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for Diabetic Peripheral Neuropathic Pain

75 locations incl. Birmingham

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All·Age: 18 - 80

Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

for Diabetes Mellitus

15 locations incl. Birmingham

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07533175·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

More research sites in Chattanooga

Southeast Renal Research Institute (5 trials)
T C Thompson Children's Hospital (5 trials)
GSK Investigational Site (4 trials)
Tennessee Oncology, PLLC - Chattanooga Downtown (4 trials)
Tennessee Oncology, PLLC - Chattanooga Med Park II (4 trials)
Tennessee Oncology, PLLC - Chattanooga Memorial (4 trials)
Erlanger Health System (4 trials)
ClinSearch, LLC (3 trials)
Erlanger Health, Inc. (3 trials)
Tennessee Oncology (3 trials)

Explore more

Paid clinical trials in Chattanooga, TN · Tennessee clinical trials